Actively Recruiting
Dose-Response Effects of Mindfulness Meditation
Led by University of Melbourne · Updated on 2025-03-30
860
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this randomized controlled trial is to test for evidence of dose-response effects in a sample of healthy adults with little to no prior experience with meditation. The main question it aims to answer is whether larger doses of mindfulness meditation yield greater positive changes in wellbeing than smaller doses. Our hypotheses are that (1) larger doses of mindfulness training will yield significantly larger effects, and (2) different doses will be significantly associated with variation in participant engagement, with lower engagement associated with higher doses. Researchers will compare each of three dose conditions, 10-min, 20-min, 30-min, against a minimal dose condition of 3-4 min. Participants will take a 28-day mindfulness meditation course, with guided audio instructions provided daily throughout the intervention period (excluding one rest day per week). They will also be asked to respond to surveys before, during, and after the intervention.
CONDITIONS
Official Title
Dose-Response Effects of Mindfulness Meditation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Reside in Australia with no plans to relocate or travel overseas during the intervention period
- Sufficient English comprehension to complete study measures
- Register for an account and agree to study terms and conditions
- If experiencing moderate anxiety or depression, agree to continue recommended medical treatment and seek help if symptoms worsen
- Have no or minimal prior meditation experience (less than 25 hours in the past 6 months and never attended a multi-day mindfulness course)
- If recruitment is slow, may include participants with up to 100 hours meditation in the past 6 months
You will not qualify if you...
- Current or lifetime serious mental illness such as neurodevelopmental, schizophrenia spectrum, bipolar, obsessive-compulsive, trauma-related, dissociative, or personality disorders
- Severe anxiety or depression symptoms above defined thresholds
- Severe psychological distress symptoms
- Scores above thresholds for mania, suicidal ideation, psychosis, repetitive thoughts/behaviors, or dissociation
- Moderate use of alcohol, tobacco, or drugs
- Diagnosed neurological conditions like traumatic brain injury, epilepsy, or stroke
- Serious medical conditions such as cancer, thyroid disorder, or multiple sclerosis
- Recent bereavement or major loss
- History of untreated traumatic experiences or adverse childhood events
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Contemplative Studies Centre, The University of Melbourne
Carlton, Victoria, Australia
Actively Recruiting
Research Team
N
Nicholas T Van Dam, PhD
CONTACT
N
Nicholas I Bowles
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here